Singtel is among the latest victims of a breach tied to Accellion s File Transfer Appliance.
Two more breaches have been tied to the vulnerable 20-year-old Accellion File Transfer Appliance. The latest victims are Singapore telecom company Singtel and Australian medical research institute QIMR Berghofer.
Singtel reports that it s working closely with the Cyber Security Agency of Singapore after a breach of its Accellion FTA system, which it uses to share information internally and externally.
In a blog post on Thursday, Singtel said it was informed by Accellion that FTA had been attacked by unidentified hackers. We are currently conducting an impact assessment with the utmost urgency to ascertain the nature and extent of data that has been potentially accessed. Customer information may have been compromised, Singtel says.
âThe interesting thing I think will be the extent to which the regulatory agencies require full-blown new clinical studies,â he said.
âIn reality, you have a completely new vaccine: it has a sequence change, it is targeting that variant. Will the regulatory authorities require a phase one, phase two, phase three trial to release those vaccines? Hopefully not, but that is their decision.â
Advertisement
The TGA did not return a request for comment by deadline.
The federal government has contracted CSL to make 50 million doses of AstraZenecaâs two-dose vaccine. The first batch is set for harvest on Monday at the companyâs Parkville campus before a six-week process of testing and filling the vaccine into vials.
Advertisement
Australian health authorities have backed AstraZenecaâs vaccine despite a decision by South African authorities to delay rolling out the jab after early clinical data showed it offered minimal protection against the COVID-19 variant spreading through that country.
Health Minister Greg Hunt on Monday confirmed AstraZenecaâs vaccine would start arriving in Australia in early March.
Health Minister Greg Hunt and Prime Minister Scott Morrison.
Credit:Alex Ellinghausen
âThe advice I received both from the Chief Medical Officer in writing and in discussion with the head of the vaccineâs taskforce Professor Brendan Murphy this morning is preliminary, but there is currently no evidence to indicate a reduction in the effectiveness of the AstraZeneca or Pfizer vaccines in preventing severe disease or death,â Mr Hunt said.